Suzuki Koichi
Department of Legal Medicine, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki, Osaka 569-8686, Japan.
Leg Med (Tokyo). 2005 Jul;7(4):205-12. doi: 10.1016/j.legalmed.2005.02.004.
The ABO blood group gene is known to code for a glycosyltransferase, which acts at the last step of sequential extension of oligosaccharide chains attached to glycoproteins or glycolipids. Since the first delineation of the molecular basis of ABO blood group, genotype-phenotype relationship of various ABO alleles has been extensively studied. Major differences between the coding sequences of them were found to reside in exons 6 and 7. Over 70 alleles have been analyzed for their sequences, more than half of which were found to exhibit hybrid nature in their sequence motifs. These alleles seem to result not from recurrent mutation but most likely from intragenic recombination due to crossing-over or genetic conversion. Occurrence of reciprocal products and de novo recombinant support the idea. The aim of this article is to outline the genetic mechanism underlying the ABO allelic diversity with a speculative model for genesis of an allele.
已知ABO血型基因编码一种糖基转移酶,该酶作用于连接在糖蛋白或糖脂上的寡糖链序列延伸的最后一步。自首次阐明ABO血型的分子基础以来,对各种ABO等位基因的基因型-表型关系进行了广泛研究。发现它们编码序列的主要差异存在于外显子6和7中。已对70多个等位基因的序列进行了分析,其中一半以上在其序列基序中表现出杂种性质。这些等位基因似乎不是由反复突变产生的,而极有可能是由于交叉或基因转换导致的基因内重组产生的。相互产物和新生重组体的出现支持了这一观点。本文的目的是概述ABO等位基因多样性背后的遗传机制,并提出一个等位基因起源的推测模型。